[Iatrogenic central serous chorioretinopathy during glucocorticoid therapy for temporal arteritis].
BACKGROUND
Visual complications of temporal arteritis are frequent and serious. Their risk prompts glucocorticoid therapy, but this treatment may also cause ophthalmologic troubles.


METHODS
A sudden and isolated monocular visual blur, occurring in a 66 years old woman after 4 month of glucocorticoid treatment for temporal arteritis, revealed a case of iatrogenic central serous chorioretinopathy. The diagnosis of this disease is established by fluorescein angiography and its functional prognosis is excellent. Tapering the doses of glucocorticoids, as fast as the underlying disease allows, hastens visual recovery.


CONCLUSIONS
When the treatment of temporal arteritis is commenced for more than a month, new visual complications are rare. Central serous chorioretinopathy induced by glucocorticoids belongs to the diagnoses that should be evoked in this case, especially if there is no clinical manifestation of arteritis and no inflammatory markers.
Steichen
O
O
Service de Médecine Interne, Hôpital Bichat, 46, Rue Henri-Huchard, 75722 Paris Cedex 18, France.
Chauveheid
M-P
MP
Lidove
O
O
Doan
S
S
Papo
T
T
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002825:Chorioretinitis / Q000139:chemically induced*; D005260:Female; D005451:Fluorescein Angiography; D013700:Giant Cell Arteritis / Q000188:drug therapy*; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007049:Iatrogenic Disease; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D011379:Prognosis; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011239:Prednisolone